Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 5, 2017 – Supernus announced the FDA approval of Trokendi XR (topiramate) extended-release capsules, for the prophylaxis of migraine headache in adults and adolescents 12 years of age and older.
Return to publications